PCV23 MEDICAL CLAIMS FOR GASTROINTESTINAL ADVERSE EVENTS ARE COMMON IN PATIENTS PRESCRIBED CLOPIDOGREL

Autor: M Goldsmith, B Cryer, DA Ollendorf, J Jermano, P Lapuerta

Publikováno v: Value in Health. 11(3)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a3b3e85affad9cc093d28e49ee53d85

PNP10 ECONOMIC IMPACT OF GLATIRAMER ACETATE IN MULTIPLE SCLEROSIS

Autor: E Jilinskaia, M Oleen-Burkey, DA Ollendorf

Publikováno v: Value in Health. 5(6):510-511

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cc01a5c3546a580a3257eae2d4b06c4

Imetelstat for anemia in lower-risk myelodysplastic syndromes: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum.

Autor: Fahim SM; Institute for Clinical and Economic Review, Boston, MA., Tice JA; Division of General Internal Medicine, University of California San Francisco., Luu L; Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle., Carlson JJ; Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle., Richardson M; Institute for Clinical and Economic Review, Boston, MA., Herce-Hagiwara B; Institute for Clinical and Economic Review, Boston, MA., Dickerson R; Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle., Ollendorf DA; Institute for Clinical and Economic Review, Boston, MA.

Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Dec; Vol. 30 (12), pp. 1479-1485.

Modeling the Population Equity of Alzheimer Disease Treatments in the US.

Autor: Synnott PG; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts., Majda T; Evidence for Access, Public Affairs and Access, Genentech, San Francisco, California., Lin PJ; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts., Ollendorf DA; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts., Zhu Y; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts., Kowal S; Evidence for Access, Public Affairs and Access, Genentech, San Francisco, California.

Publikováno v: JAMA network open [JAMA Netw Open] 2024 Oct 01; Vol. 7 (10), pp. e2442353. Date of Electronic Publication: 2024 Oct 01.

Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review.

Autor: Thavorn K; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada; Pharmacoepidemiology and Statistics Research Center, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand. Electronic address: kthavorn@ohri.ca., Thompson ER; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada., Kumar S; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada., Heiskanen A; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada., Agarwal A; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada., Atkins H; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Transplant and Cell Therapy Program, Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada., Shorr R; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada., Hawrysh T; Patient Partner, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada., Chan KK; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada., Presseau J; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada., Ollendorf DA; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; Institute for Clinical and Economic Review, Boston, MA, USA., Graham ID; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada., Grimshaw JM; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada; Department of Medicine, University of Ottawa, Ottawa, ON, Canada., Lalu MM; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada; Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON, Canada., Nochaiwong S; Pharmacoepidemiology and Statistics Research Center, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand., Fergusson DA; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada., Hutton B; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada., Coyle D; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada., Kekre N; Clinical Epidemiology Program, Ottawa Hospital Research Institute, General Campus, Ottawa, ON, Canada; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Transplant and Cell Therapy Program, Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Aug; Vol. 27 (8), pp. 1149-1173. Date of Electronic Publication: 2024 Apr 17.